AllazoHealth partnered with a top 10 rare diseases company to enhance the patient’s therapy journey and improve patient support programs with AI-enabled targeted and personalized communications. The global company is dedicated to serving patients affected by the devastating conditions of rare diseases through development and commercialization of life-changing medicines.
The Challenge
Increasing patient engagement for successful therapy initiation, adherence, and positive outcomes
The rare diseases pharma company developed innovative therapies for a range of conditions, yet was challenged to keep patients engaged in their patient support programs, as well as initiate prescribed therapies and stay on them. Therapies had a variety of administration methods including clinic infusion, home infusion, self-injection, and oral. Additionally, nurses supported patients with live phone calls, which were high touch but costly. Patient engagement is vital to successful therapy initiation, adherence, and positive outcomes.
The Solution
Tailoring the patient journey at the individual level and streamline nurse call workflows
AllazoHealth’s AI-enabled personalization was implemented to tailor the patient journey at the individual level and streamline the call center workflows for nurses. The AI technology enhances support for patients by helping them start and stay on therapy, adhere to treatment, receive necessary injections, and attend infusion appointments. It also supports getting benefits verified and prior authorizations quickly completed.
The Results
Double digit increases in therapy initiation
Within five months of implementation, the rare diseases company saw the following results:
- Increased therapy initiation by 10.4%
- Decreased therapy discontinuation by 7.3%
To learn more, access the case study now.